Lin28 is weakly expressed in normal differentiated cells but dysregulated in cancer cells, resulting in the initiation of a cascade of reactions leading to cancer cells gaining stemness, mobility, and enhanced therapy resistance [20]. The gene discussed is LIN28A; the disease is cancer.